Cat# : VAC-0006
Cat#: | VAC-0006 |
Product Name: | Recombinant Dendritic Cells Vaccine |
Description: | The recombinant chimeric DC vaccine is a subunit-based vaccine candidate investigated for safety and effectiveness against SARS-CoV-2-induced pneumonia. With a better safety profile than inactivated and live-attenuated virus and virus-vector vaccines, the recombinant chimeric DC vaccine reduces the risk of virulence recovery, pre-existing anti-vector immunity, and incomplete viral inactivation. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. |
Biologic Classification: | Vaccines Recombinant |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.